Solid phase synthesis of 5-hydroxymethyluracil containing DNA

[1]  D. D. Levy,et al.  Site directed substitution of 5-hydroxymethyluracil for thymine in replicating phi X-174am3 DNA via synthesis of 5-hydroxymethyl-2'-deoxyuridine-5'-triphosphate. , 1991, Nucleic acids research.

[2]  B. Reid,et al.  Solution structure of the EcoRI DNA sequence: refinement of NMR-derived distance geometry structures by NOESY spectrum back-calculations. , 1989, Biochemistry.

[3]  J. Vilpo,et al.  Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60). , 1988, Cancer research.

[4]  E. De Clercq,et al.  Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase. , 1987, Molecular pharmacology.

[5]  L. Kangas,et al.  Antileukemic activity against L1210 leukemia, pharmacokinetics and hematological side effects of 5-hydroxymethyl-2'-deoxyuridine. , 1987, Leukemia research.

[6]  E. Geiduschek,et al.  Site‐specific DNA binding by the bacteriophage SP01‐encoded type II DNA‐binding protein. , 1985, The EMBO journal.

[7]  K. K. Ogilvie,et al.  New catalysts and procedures for the dimethoxytritylation and selective silylation of ribonucleosides , 1982 .

[8]  R. Schinazi,et al.  Synthesis and biological activities of 5-(hydroxymethyl, azidomethyl, or aminomethyl)-2'-deoxyuridine and related 5'-substituted analogues. , 1980, Journal of medicinal chemistry.

[9]  E. Geiduschek,et al.  Specificity of the weak binding between the phage SPO1 transcription-inhibitory protein, TF1, and SPO1 DNA. , 1977, Biochemistry.

[10]  R. Kallen,et al.  The new occurrence of a new pyrimidine base replacing thymine in a bacteriophage DNA:5-hydroxymethyl uracil. , 1962, Journal of molecular biology.